Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,288 BCRX shares, $12.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 1,288 | $12.5K |
| Jun 15, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 15,294 | n/a |
| Jun 2, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 1,262 | $11.2K |
| Mar 3, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 528 | $4.6K |
| Jan 27, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 2,582 | n/a |
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 4,377 | n/a |
| Mar 25, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 761,000 | n/a |
| Feb 12, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 534,600 | n/a |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 275,000 | n/a |
| Mar 4, 2022 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 195,000 | n/a |